Response to: Combined treatment of intravitreal bevacizumab and intravitreal triamcinolone in patients with retinal vein occlusion by Schroff et al.

Rita Ehrlich; Thomas A. Ciulla; Adam Moss; Alon Harris

doi:10.1007/s00417-010-1354-5

Response to: Combined treatment of intravitreal bevacizumab and intravitreal triamcinolone in patients with retinal vein occlusion by Schroff et al.

Rita Ehrlich, Thomas A. Ciulla, Adam Moss, Alon Harris

Research output: Contribution to journal › Letter › peer-review

1 Scopus citations

Original language	English
Pages (from-to)	305
Number of pages	1
Journal	Graefe's Archive for Clinical and Experimental Ophthalmology
Volume	249
Issue number	2
DOIs	https://doi.org/10.1007/s00417-010-1354-5
State	Published - Feb 2011
Externally published	Yes

Access to Document

10.1007/s00417-010-1354-5

Cite this

@article{36fa3a1910aa4596a845b60260187442,

title = "Response to: Combined treatment of intravitreal bevacizumab and intravitreal triamcinolone in patients with retinal vein occlusion by Schroff et al.",

author = "Rita Ehrlich and Ciulla, {Thomas A.} and Adam Moss and Alon Harris",

year = "2011",

month = feb,

doi = "10.1007/s00417-010-1354-5",

language = "English",

volume = "249",

pages = "305",

journal = "Graefe's Archive for Clinical and Experimental Ophthalmology",

issn = "0721-832X",

publisher = "Springer Verlag",

number = "2",

}

TY - JOUR

T1 - Response to

T2 - Combined treatment of intravitreal bevacizumab and intravitreal triamcinolone in patients with retinal vein occlusion by Schroff et al.

AU - Ehrlich, Rita

AU - Ciulla, Thomas A.

AU - Moss, Adam

AU - Harris, Alon

PY - 2011/2

Y1 - 2011/2

UR - http://www.scopus.com/inward/record.url?scp=79952438919&partnerID=8YFLogxK

U2 - 10.1007/s00417-010-1354-5

DO - 10.1007/s00417-010-1354-5

M3 - Letter

C2 - 20352444

AN - SCOPUS:79952438919

SN - 0721-832X

VL - 249

SP - 305

JO - Graefe's Archive for Clinical and Experimental Ophthalmology

JF - Graefe's Archive for Clinical and Experimental Ophthalmology

IS - 2

ER -